For ALS patients, doctors, a new medicine reignites concerns about healthcare access
Bio Pharma Dive
DECEMBER 15, 2022
Relyvrio, a drug developed by Amylyx Pharmaceuticals, is in high demand in ALS clinics across the U.S. Though some patients are already getting it, insurance coverage and out-of-pocket costs remain a source of anxiety.
Let's personalize your content